Tag Archives: Alzheimers

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval

House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval House Committees Demand F.D.A. Records on Alzheimer’s Drug Approval Two powerful congressional committees investigating the controversial federal approval of Biogen’s Alzheimer’s drug, Aduhelm, demanded extensive information and documents from the Food and Drug Administration on Thursday, making it clear that the committees’ leaders are troubled by unusual actions the agency took …

Read More »

My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else?

My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else?

My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else? My Stepdad Has Alzheimer’s. Can My Mom Date Someone Else? When I was a child, my parents had some huge fights about some books my dad stole from the marvelous library of the university he attended on the G.I. Bill. They were 10 bound volumes of Harper’s Bazaar from the …

Read More »

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved

How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved How Aduhelm, an Unproven Alzheimer’s Drug, Got Approved The idea of accelerated approval came up briefly toward the end, raised by Dr. Rick Pazdur, head of F.D.A.’s oncology center, who was not a council member. It was not discussed in detail, but after the meeting, given the council’s rejection of standard approval, …

Read More »

Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients

Ohio Clinic Says It Won't Administer Alzheimer's Drug to Patients

Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients Ohio Clinic Says It Won’t Administer Alzheimer’s Drug to Patients In a striking reflection of concern over the approval of the controversial new Alzheimer’s drug Aduhelm, the Cleveland Clinic said Wednesday evening that it would not administer it to patients. The clinic, one of the largest and most respected medical …

Read More »

F.D.A. Requests Investigation of Its Own Alzheimer’s Drug Approval

F.D.A. Requests Investigation of Its Own Alzheimer’s Drug Approval

F.D.A. Requests Investigation of Its Own Alzheimer’s Drug Approval F.D.A. Requests Investigation of Its Own Alzheimer’s Drug Approval The Food and Drug Administration on Friday called for a federal investigation of the process that led to the approval of a new drug for Alzheimer’s disease that has spurred sharp criticism from lawmakers and the medical community. In a letter to …

Read More »

In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug

Instagram Tries Clamping Down on Misinformation

In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug In a Reversal, F.D.A. Calls for Limits on Who Gets Alzheimer’s Drug Facing sharp criticism for approving a controversial drug for all Alzheimer’s patients, the Food and Drug Administration has greatly narrowed its recommendation, suggesting that only those with mild memory or thinking problems should receive it. The …

Read More »

A New Alzheimer’s Drug Offers More Questions Than Answers

A New Alzheimer’s Drug Offers More Questions Than Answers

A New Alzheimer’s Drug Offers More Questions Than Answers A New Alzheimer’s Drug Offers More Questions Than Answers “It puts us in a bad place,” agreed Dr. Karina Bishop, a geriatrician at the University of Nebraska Medical Center. Ethically, she added, “if this drug was available right now, I would not feel able to prescribe it.” Even as individual doctors …

Read More »

New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA

New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA

New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA New Alzheimer’s Drug Could Cost the Government as Much as It Spends on NASA A newly approved drug to treat Alzheimer’s disease is expected to become a multibillion dollar expense for Medicare. By one projection, spending on the drug for Medicare’s patients could end up being …

Read More »

Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited

Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited

Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited Dr. Salloway, a site principal investigator for trials of the drug, wasn’t paid for that work but has received research and consulting fees from Biogen. He said doctors should use the drug only for patients whose statuses match …

Read More »

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug

Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug Three F.D.A. Advisers Resign Over Agency’s Approval of Alzheimer’s Drug In a powerful statement of disagreement with the Food and Drug Administration’s approval of Biogen’s controversial Alzheimer’s drug this week, three scientists have resigned from the independent committee that advised the agency on the treatment. “This might be the worst …

Read More »